Lemieux Stephen 4
4 · Edesa Biotech, Inc. · Filed Aug 4, 2023
Insider Transaction Report
Form 4
Lemieux Stephen
Chief Financial Officer
Transactions
- Award
Common Shares
2023-08-04+17,400→ 17,400 total
Footnotes (1)
- [F1]Reflects a grant of restricted share units ("RSUs"), which vested in full upon grant, pursuant to the Issuer's 2019 Equity Incentive Compensation Plan. These RSUs represent awards received in lieu of certain compensation fees earned by Reporting Person. The number of RSUs was determined by dividing such fees by the 5-day volume weighted average price (VWAP) of the Issuer's common shares through July 31, 2023.